Copyright Reports & Markets. All rights reserved.

Global Amikacin Sulfate API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Amikacin Sulfate API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity≥99%
    • 1.3.3 Purity<99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Amikacin Sulfate API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Injection
    • 1.4.3 Suspension
  • 1.5 Global Amikacin Sulfate API Market Size & Forecast
    • 1.5.1 Global Amikacin Sulfate API Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Amikacin Sulfate API Sales Quantity (2021-2032)
    • 1.5.3 Global Amikacin Sulfate API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 ACS DOBFAR SPA
    • 2.1.1 ACS DOBFAR SPA Details
    • 2.1.2 ACS DOBFAR SPA Major Business
    • 2.1.3 ACS DOBFAR SPA Amikacin Sulfate API Product and Services
    • 2.1.4 ACS DOBFAR SPA Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 ACS DOBFAR SPA Recent Developments/Updates
  • 2.2 SHANDONG ANXIN PHARMACEUTICAL CO LTD
    • 2.2.1 SHANDONG ANXIN PHARMACEUTICAL CO LTD Details
    • 2.2.2 SHANDONG ANXIN PHARMACEUTICAL CO LTD Major Business
    • 2.2.3 SHANDONG ANXIN PHARMACEUTICAL CO LTD Amikacin Sulfate API Product and Services
    • 2.2.4 SHANDONG ANXIN PHARMACEUTICAL CO LTD Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SHANDONG ANXIN PHARMACEUTICAL CO LTD Recent Developments/Updates
  • 2.3 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd.
    • 2.3.1 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd. Details
    • 2.3.2 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd. Major Business
    • 2.3.3 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd. Amikacin Sulfate API Product and Services
    • 2.3.4 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd. Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.4 Sichuan Ren'an Pharmaceutical
    • 2.4.1 Sichuan Ren'an Pharmaceutical Details
    • 2.4.2 Sichuan Ren'an Pharmaceutical Major Business
    • 2.4.3 Sichuan Ren'an Pharmaceutical Amikacin Sulfate API Product and Services
    • 2.4.4 Sichuan Ren'an Pharmaceutical Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sichuan Ren'an Pharmaceutical Recent Developments/Updates
  • 2.5 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory
    • 2.5.1 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory Details
    • 2.5.2 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory Major Business
    • 2.5.3 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory Amikacin Sulfate API Product and Services
    • 2.5.4 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory Recent Developments/Updates
  • 2.6 Zhejiang Yongning Pharmaceutical
    • 2.6.1 Zhejiang Yongning Pharmaceutical Details
    • 2.6.2 Zhejiang Yongning Pharmaceutical Major Business
    • 2.6.3 Zhejiang Yongning Pharmaceutical Amikacin Sulfate API Product and Services
    • 2.6.4 Zhejiang Yongning Pharmaceutical Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Zhejiang Yongning Pharmaceutical Recent Developments/Updates
  • 2.7 Livzon Group Fuzhou Fuxing Pharmaceutical
    • 2.7.1 Livzon Group Fuzhou Fuxing Pharmaceutical Details
    • 2.7.2 Livzon Group Fuzhou Fuxing Pharmaceutical Major Business
    • 2.7.3 Livzon Group Fuzhou Fuxing Pharmaceutical Amikacin Sulfate API Product and Services
    • 2.7.4 Livzon Group Fuzhou Fuxing Pharmaceutical Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Livzon Group Fuzhou Fuxing Pharmaceutical Recent Developments/Updates
  • 2.8 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical
    • 2.8.1 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical Details
    • 2.8.2 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical Major Business
    • 2.8.3 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical Amikacin Sulfate API Product and Services
    • 2.8.4 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Peking University Pharmaceutical Chongqing Daxin Pharmaceutical Recent Developments/Updates
  • 2.9 Chengdu Best Pharmaceutical
    • 2.9.1 Chengdu Best Pharmaceutical Details
    • 2.9.2 Chengdu Best Pharmaceutical Major Business
    • 2.9.3 Chengdu Best Pharmaceutical Amikacin Sulfate API Product and Services
    • 2.9.4 Chengdu Best Pharmaceutical Amikacin Sulfate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Chengdu Best Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Amikacin Sulfate API by Manufacturer

  • 3.1 Global Amikacin Sulfate API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Amikacin Sulfate API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Amikacin Sulfate API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Amikacin Sulfate API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Amikacin Sulfate API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Amikacin Sulfate API Manufacturer Market Share in 2025
  • 3.5 Amikacin Sulfate API Market: Overall Company Footprint Analysis
    • 3.5.1 Amikacin Sulfate API Market: Region Footprint
    • 3.5.2 Amikacin Sulfate API Market: Company Product Type Footprint
    • 3.5.3 Amikacin Sulfate API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Amikacin Sulfate API Market Size by Region
    • 4.1.1 Global Amikacin Sulfate API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Amikacin Sulfate API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Amikacin Sulfate API Average Price by Region (2021-2032)
  • 4.2 North America Amikacin Sulfate API Consumption Value (2021-2032)
  • 4.3 Europe Amikacin Sulfate API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Amikacin Sulfate API Consumption Value (2021-2032)
  • 4.5 South America Amikacin Sulfate API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Amikacin Sulfate API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 5.2 Global Amikacin Sulfate API Consumption Value by Type (2021-2032)
  • 5.3 Global Amikacin Sulfate API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 6.2 Global Amikacin Sulfate API Consumption Value by Application (2021-2032)
  • 6.3 Global Amikacin Sulfate API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 7.2 North America Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 7.3 North America Amikacin Sulfate API Market Size by Country
    • 7.3.1 North America Amikacin Sulfate API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Amikacin Sulfate API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Amikacin Sulfate API Market Size by Country
    • 8.3.1 Europe Amikacin Sulfate API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Amikacin Sulfate API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Amikacin Sulfate API Market Size by Region
    • 9.3.1 Asia-Pacific Amikacin Sulfate API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Amikacin Sulfate API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 10.2 South America Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 10.3 South America Amikacin Sulfate API Market Size by Country
    • 10.3.1 South America Amikacin Sulfate API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Amikacin Sulfate API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Amikacin Sulfate API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Amikacin Sulfate API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Amikacin Sulfate API Market Size by Country
    • 11.3.1 Middle East & Africa Amikacin Sulfate API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Amikacin Sulfate API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Amikacin Sulfate API Market Drivers
  • 12.2 Amikacin Sulfate API Market Restraints
  • 12.3 Amikacin Sulfate API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Amikacin Sulfate API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Amikacin Sulfate API
  • 13.3 Amikacin Sulfate API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Amikacin Sulfate API Typical Distributors
  • 14.3 Amikacin Sulfate API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Amikacin Sulfate API market size was valued at US$ 207 million in 2025 and is forecast to a readjusted size of US$ 271 million by 2032 with a CAGR of 4.0% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Amikacin Sulfate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Amikacin Sulfate API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Amikacin Sulfate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Amikacin Sulfate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
    Global Amikacin Sulfate API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Amikacin Sulfate API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Amikacin Sulfate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ACS DOBFAR SPA, SHANDONG ANXIN PHARMACEUTICAL CO LTD, Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd., Sichuan Ren'an Pharmaceutical, Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory, Zhejiang Yongning Pharmaceutical, Livzon Group Fuzhou Fuxing Pharmaceutical, Peking University Pharmaceutical Chongqing Daxin Pharmaceutical, Chengdu Best Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Amikacin Sulfate API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity≥99%
    Purity<99%
    Market segment by Application
    Injection
    Suspension
    Major players covered
    ACS DOBFAR SPA
    SHANDONG ANXIN PHARMACEUTICAL CO LTD
    Zhejiang Jinhua Kangenba Biopharmaceutical Co., Ltd.
    Sichuan Ren'an Pharmaceutical
    Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou Pharmaceutical Factory
    Zhejiang Yongning Pharmaceutical
    Livzon Group Fuzhou Fuxing Pharmaceutical
    Peking University Pharmaceutical Chongqing Daxin Pharmaceutical
    Chengdu Best Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Amikacin Sulfate API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Amikacin Sulfate API, with price, sales quantity, revenue, and global market share of Amikacin Sulfate API from 2021 to 2026.
    Chapter 3, the Amikacin Sulfate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Amikacin Sulfate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Amikacin Sulfate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Amikacin Sulfate API.
    Chapter 14 and 15, to describe Amikacin Sulfate API sales channel, distributors, customers, research findings and conclusion.

    Buy now